Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T van Gelder

Showing results (121-130 of 169) with videos related to

Pageof 17
Sort By:
Transplantation Proceedings|June 24, 1998
Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipientsP J Smak Gregoor, C J Hesse, T van Gelder, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocolP J Smak Gregoor, T van Gelder, N M van Besouw, et al.
Drug Discovery Today|November 28, 2025
Academic-industry collaboration in biomedical innovation: A multi-model review of barriers and facilitatorsJ C J Loggers, M E J Reinders, T van Gelder, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
BMC Cardiovascular Disorders|February 15, 2023
The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trialL E J Peeters, M H W Kappers, E Boersma, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 17, 2003
Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrationsP J H Smak Gregoor, T van Gelder, I C van Riemsdijk-van Overbeeke, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 20, 1998
The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantationC C Baan, C T Holweg, H G Niesters, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 19, 2019
Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertensionL E J Peeters, M P Kester, L Feyz, et al.
Transplantation Proceedings|June 24, 1998
Contribution of the inflammatory response to cardiac allograft rejection: histopathologic analysis of serial endomyocardial biopsiesC C Baan, C J Knoop, T van Gelder, et al.
Transplantation Proceedings|December 1, 1999
The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantationC C Baan, C J Knoop, C T Holweg, et al.
Pageof 17

Showing results (121-130 of 169) with videos related to

Sort By:
Pageof 17
Transplantation Proceedings|June 24, 1998
Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipientsP J Smak Gregoor, C J Hesse, T van Gelder, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Mycophenolic acid trough levels after kidney transplantation in a cyclosporine-free protocolP J Smak Gregoor, T van Gelder, N M van Besouw, et al.
Drug Discovery Today|November 28, 2025
Academic-industry collaboration in biomedical innovation: A multi-model review of barriers and facilitatorsJ C J Loggers, M E J Reinders, T van Gelder, et al.
British Journal of Cancer|February 16, 2013
Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugsR W F van Leeuwen, D H S Brundel, C Neef, et al.
BMC Cardiovascular Disorders|February 15, 2023
The effect of combining therapeutic drug monitoring of antihypertensive drugs with personalised feedback on adherence and resistant hypertension: the (RHYME-RCT) trial protocol of a multi-centre randomised controlled trialL E J Peeters, M H W Kappers, E Boersma, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 17, 2003
Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrationsP J H Smak Gregoor, T van Gelder, I C van Riemsdijk-van Overbeeke, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 20, 1998
The nature of acute rejection is associated with development of graft vascular disease after clinical heart transplantationC C Baan, C T Holweg, H G Niesters, et al.
Expert Opinion on Drug Metabolism & Toxicology|March 19, 2019
Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertensionL E J Peeters, M P Kester, L Feyz, et al.
Transplantation Proceedings|June 24, 1998
Contribution of the inflammatory response to cardiac allograft rejection: histopathologic analysis of serial endomyocardial biopsiesC C Baan, C J Knoop, T van Gelder, et al.
Transplantation Proceedings|December 1, 1999
The macrophage-derived T-cell growth factor interleukin-15 is present in interleukin-2-independent rejection after clinical heart and liver transplantationC C Baan, C J Knoop, C T Holweg, et al.
Pageof 17